Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Eli Lilly supports Alto Neuroscience in $45m Series C round
Clinical Trials Arena
Wed, 11/22/23 - 11:30 am
Eli Lilly
Alto Neuroscience
funding
psychiatric diesase
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
Mon, 11/20/23 - 11:32 am
weightloss
Novo Nordisk
Eli Lilly
Pfizer
AstraZeneca
Wegovy
Zepbound
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Fri, 11/17/23 - 10:02 am
Lonza
drug manufacturing
obesity
Novo Nordisk
Eli Lilly
Why Eli Lilly Stock Flopped While the Market Popped Today
Motley Fool
Wed, 11/15/23 - 11:47 pm
Eli Lilly
Europe
drug manufacturing
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Wed, 11/15/23 - 12:04 pm
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
BioSpace
Mon, 11/13/23 - 11:58 am
ViaNautis Bio
Eli Lilly
genetic nanomedicine
UCB Pharma
funding
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
Pharmaphorum
Mon, 11/13/23 - 10:03 am
Eli Lilly
AHA
siRNA
lipoprotein(a)
cardiovascular disease
lepodisiran
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Sun, 11/12/23 - 09:21 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.
Motley Fool
Fri, 11/10/23 - 12:19 pm
Eli Lilly
donanemab
tirzepatide
mirikizumab
lebrikizumab
pirtobrutinib
How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets
Medical Marketing and Media
Thu, 11/9/23 - 11:41 pm
Eli Lilly
tirzepatide
weightloss
Zepbound
Mounjaro
FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management
BioSpace
Wed, 11/8/23 - 10:05 pm
Eli Lilly
Zepbound
FDA
weightloss
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
BioPharma Dive
Tue, 11/7/23 - 09:50 am
OrsoBio
Eli Lilly
funding
obesity
diabetes
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
BioSpace
Sun, 11/5/23 - 11:12 pm
Novo Nordisk
Eli Lilly
Wegovy
Mounjaro
weightlosss
Eli Lilly Just Added Another Potential Billion-Dollar Product
Motley Fool
Sun, 11/5/23 - 11:08 pm
Eli Lilly
ulcerative colitis
Omvoh
Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist
Reuters
Thu, 11/2/23 - 11:44 am
Eli Lilly
earnings
Mounjaro
Eli Lilly, Redwire head to space to explore next frontier of drug development
Fierce Pharma
Tue, 10/31/23 - 10:08 am
Eli Lilly
drug development
Redwire
PIL-BOX
in-space manufacturing
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Tue, 10/31/23 - 10:06 am
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Sun, 10/29/23 - 08:44 pm
Roche
Eli Lilly
Pfizer
IBD
ulcerative colitis
Crohn's Disease
mirikizumab
Lilly’s ulcerative colitis therapy mirikizumab finally snags FDA approval
BioSpace
Fri, 10/27/23 - 11:54 am
Eli Lilly
ulcerative colitis
mirikizumab
Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide
Fierce Biotech
Thu, 10/26/23 - 10:46 pm
Eli Lilly
BioAge Labs
muscle regeneration
tirzepatide
Mounjaro
BGE-105
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »